Sun Pharma recalls more than 24K pre-filled syringes of generic medicine
According to the US health agency, Sun Pharmaceutical Industries, a major pharmaceutical company, is recalling pre-filled syringes of a medication […]
Say something
According to the US health agency, Sun Pharmaceutical Industries, a major pharmaceutical company, is recalling pre-filled syringes of a medication […]
Sun Pharmaceutical Industries revealed that it acquired a small share in both Agatsa Software Private Limited and Remidio Innovative Solutions […]
Drug major Sun Pharma has inked a licensing pact with AstraZeneca UK to introduce certain novel ready-to-use infusion oncology products […]
Sun Pharmaceutical Industries on Thursday said one of its arms has entered into a licensing pact with a subsidiary of […]
Sun Pharma recently made an announcement to acquire Japan-based Pola Pharma. The deal, which will help Sun Pharma to strengthen its […]
Yashwant Mahadik has been appointed as President, Global Human Resources, Lupin announced on Tuesday. In an official statement, the drug […]
The Indian Council of Medical Research (ICMR), the apex body for the formulation, coordination and promotion of biomedical research, is […]
Drug major Sun Pharma, an Indian multinational pharmaceutical company headquartered in Mumbai, on July 13 announced a slew of changes […]
According to a recent statement, Kalyanasundaram Subramanian, popularly known as Kal Sundaram, CEO of Taro Pharmaceutical Industries Ltd (Taro), the […]
In focus to bring Ranbaxy facilities to compliance, Sun Pharma sees immense opportunities for expanding its operations in Punjab. According […]
Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories are trading higher by 2 percent. Sun Pharma stock surged 2 percent […]
Lisinopril recall may not affect the company financially Drug-maker Lupin’s hypertension drug Lisinopril, in the US, recall will not have […]
Health Application in Demand Straub Clinic and Hospital and Kauai Medical Clinic becomes the first healthcare facility centre to allow […]